Suppr超能文献

从A组14型化脓性链球菌分离出的核糖体疫苗的免疫原性。

Immunogenicity of ribosomal vaccines isolated from group A, type 14 Streptococcus pyogenes.

作者信息

Schalla W O, Johnson W

出版信息

Infect Immun. 1975 Jun;11(6):1195-202. doi: 10.1128/iai.11.6.1195-1202.1975.

Abstract

A ribosomal preparation isolated from group A, type 14 Streptococcus pyogenes protected mice against a challenge of 1,000 mean lethal doses. Optimal immunization consisted of subcutaneous administration of 326 mug of protein with Freund incomplete adjuvant. Animals immunized with higher or lower antigen concentrations showed decreased survival. Freund incomplete adjuvant was necessary to insure optimum immunization. Immunochemical studies showed no M protein or C carbohydrate present in the ribosomal preparation. Mice optimally immunized with the type 14 ribosomal preparation were protected against heterologous challenge with M types 2, 5, 8, and 12. Protein-free ribonucleic acid extracts isolated from the type 14 ribosomal preparation did not protect mice against homologous challenge. But ribonucleic acid-free protein extracts showed 100% protection in mice after homologous challenge.

摘要

从A组14型化脓性链球菌分离出的核糖体制剂可保护小鼠免受1000个平均致死剂量的攻击。最佳免疫方法是皮下注射326微克蛋白质与弗氏不完全佐剂。用更高或更低抗原浓度免疫的动物存活率降低。弗氏不完全佐剂对于确保最佳免疫是必要的。免疫化学研究表明核糖体制剂中不存在M蛋白或C碳水化合物。用14型核糖体制剂进行最佳免疫的小鼠可免受2型、5型、8型和12型M型的异源攻击。从14型核糖体制剂中分离出的无蛋白核糖核酸提取物不能保护小鼠免受同源攻击。但无核糖核酸的蛋白质提取物在同源攻击后对小鼠显示出100%的保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e9/415199/cd1c75840e49/iai00234-0035-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验